medroxyprogesterone acetate
medroxyprogesterone acetate is listed in the FDA National Drug Code directory with 25 NDC codes, marketed under brand names including Depo-Provera, medroxyprogesterone acetate, Provera. Available dosage forms: injection, suspension, tablet, powder.
Drug details
- Generic Name
- medroxyprogesterone acetate
- Brand Names
- Depo-Provera, medroxyprogesterone acetate, Provera, Depo-SubQ Provera, Medroxyprogesterone Acetate Injectable Suspension
- Application Number
- NDA020246
- Sponsor
- Pharmacia & Upjohn Company LLC
- NDC Codes
- 25
- Dosage Forms
- INJECTION, SUSPENSION, TABLET, POWDER
- Routes
- INTRAMUSCULAR, ORAL, SUBCUTANEOUS
- Active Ingredients
- MEDROXYPROGESTERONE ACETATE
Indications and Usage
1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e. longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ] . Medroxyprogesterone acetate injectable suspension is a progestin indicated for use by females of reproductive potential to prevent pregnancy. (1) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. (1 , 5.1)